4th National Hepatitis Conference 2019

7-8 March 2019
Kuala Lumpur, Malaysia

  • François Bompart, Director of Paediatric HIV/HCV Programmes – panel discussion on collaborative R&D model for hepatitis C
  • Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes – presentation of the HCV STORM Stage 1 results

CTDDR 2019

20-23 February 2019
Lucknow, India

  • Presentation of the development of DNDI-0690, a new clinical candidate for visceral leishmaniasis

Sixth International Conference on Mycetoma

15-17 February 2019
Khartoum, Sudan

  • DNDi – co-sponsoring the event and presentation on the open innovation project MycetOS
  • Monique Wasuna, Director DNDi Africa – chair for a session on international collaboration for mycetoma
  • Nathalie Strub-Wourgaft, NTD Director – session on the way forward for mycetoma

ASTMH 2018

67th Annual Meeting

28 October – 1 November 2018
New Orleans, USA

  • Nathalie Strub-Wourgaft, NTD Director – presentation on fexinidazole in a symposium on sleeping sickness elimination
  • Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme – symposium on screening and diagnosis of Chagas disease
  • Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma

COR-NTD Annual Meeting

26-27 October 2018
New Orleans, USA

  • Sergio Sosa-Estani, Head of Chagas Clinical Program, and Andrea Marchiol, Chagas Access Project Manager – session on control and care of Chagas disease in health networks
  • Suman Rijal, Head Regional Office, DNDi India – presentation on VL/HIV co-infections and PKDL

Keystone Conference 2018

21st Century Drug Discovery and Development for Global Health

17-20 October 2018
Berlin, Germany

  • Nathalie Strub-Wourgaft, NTD Director – presentation on the new therapies for sleeping sickness
  • Charles Mowbray, Discovery Director – presentation on new orally active treatments for leishmaniasis

11th DNDi Partners’ Meeting: From innovation to access in Africa – the way forward

4 October 2018
Kampala, Uganda

  • DNDi’s biannual partners’ meeting will bring together some 250-300 health leaders, policy-makers, researchers, civil society groups, product developers, and donors.
  • Meeting sessions will highlight the significant changes made and those still needed in the landscape of research and development, capacity building and strengthening, and access to medicines for neglected diseases and patients on the African continent.

Paediatric HIV Stakeholders’ Meeting

3-4 October 2018
Kampala, Uganda

  • François Bompart, Director of Paediatric HIV/HCV Programmes, Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes, Jean-René Kiechel,Expert in R&D – panel discussion on DNDi‘s journey so far working on Paediatric HIV
  • Olawale Salami, Paediatric HIV Clinical Project Manager – panel discussion on access to child-adapted ARV formulations

Onchocerciasis Network Meeting

3-4 October 2018
Kampala, Uganda

  • Sabine Specth, Head of Filariasis Clinical Programme – presentation of unmet medical need of onchocerciasis patients and Target Product Profile
  • Belén Pedrique, Medical Manager – presentation on access strategies for new treatments for onchocerciasis
  • Florent Mbo, HAT Platform Coordinator – presentation of the HAT Platform

25th LEAP Platform Meeting

3-4 October 2018
Kampala, Uganda

  • DNDi – sessions on the LEAP Platform activities, policy, the AfriKADIA project, PKDL, and capacity strengthening